68 results
Page 3 of 4
DEF 14A
xf301t
22 Nov 21
Definitive proxy
4:37pm
D
72bxutt0aw
26 Oct 21
$5.92M in options / securities to be acquired, 10 investors
1:39pm
8-K
EX-10.1
rtffd6 w51tmo
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
f7pg1s8
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
zahe wel4o9a20
14 May 21
Quarterly report
4:31pm
10-K
EX-10.9
qz9jn
31 Mar 21
Annual report
4:30pm
10-K
EX-10.1
3029d5e2tw3r ds
31 Mar 21
Annual report
4:30pm
10-K
31ke whyeco0cyby2b
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
bpbl3 espu665v6s8pxb
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
uq97y5 1le3pmgimztu
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.3
k2d 0v4e40aoup9rp
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.4
p9hb1e o51
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
1iicflm2r8
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-10.1
ddr81vp cd99tbae
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.1
2hs9g1g ltim0p5w
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
172ex7rhr
2 Nov 20
Prospectus supplement
12:00am